Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00664456
What this trial is testing

Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer

Who this might be right for
Prostate Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 421
Large-scale testing (Phase 3)Looking for participantsNCT05019846
What this trial is testing

SRT Versus SRT+ADT in Prostate Cancer

Who this might be right for
Prostate Cancer
Marco Lorenzo Bonu 310
Testing effectiveness (Phase 2)Study completedNCT02874014
What this trial is testing

Hypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 56
Testing effectiveness (Phase 2)WithdrawnNCT00598858
What this trial is testing

Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateStage I Prostate Cancer+1 more
John P. Fruehauf
Not applicableActive Not RecruitingNCT03383016
What this trial is testing

Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)

Who this might be right for
EpidemiologyProstate Cancer
CHU de Quebec-Universite Laval 2,053
Not applicableActive Not RecruitingNCT06451614
What this trial is testing

SpaceIT Hydrogel System for Perirectal Spacing

Who this might be right for
Prostate Cancer
Boston Scientific Corporation 230
Testing effectiveness (Phase 2)UnknownNCT01909388
What this trial is testing

Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy

Who this might be right for
Prostate Cancer
Alfonso Gomez-Iturriaga 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04025372
What this trial is testing

INTREPId (INTermediate Risk Erection PreservatIon Trial)

Who this might be right for
Prostate Cancer
Brigham and Women's Hospital 234
Not applicableUnknownNCT03979573
What this trial is testing

Prospective Evaluation of Mp-MRI, MR-guided Biopsy, and Molecular Markers for Active Surveillance of Prostate Cancer

Who this might be right for
Prostate Cancer
Heinrich-Heine University, Duesseldorf 90
Testing effectiveness (Phase 2)Study completedNCT03113617
What this trial is testing

68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer

Who this might be right for
Stage II Prostate AdenocarcinomaStage III Prostate AdenocarcinomaStage IV Prostate Adenocarcinoma
Andrei Iagaru 44
Not applicableUnknownNCT02790216
What this trial is testing

Deformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate Brachytherapy

Who this might be right for
Prostate Cancer
Sheba Medical Center 24
Not applicableWithdrawnNCT02546427
What this trial is testing

Hypofractionated Whole Pelvic Radiotherapy of the Prostate

Who this might be right for
Prostate Cancer
Albert J. Chang
Not applicableStudy completedNCT02125175
What this trial is testing

BIOPROP20: Biologically Optimised IMRT for Prostate Radiotherapy Hypofractionated Radiotherapy With Intra-prostatic Boosts to Tumour Nodules in Men With Intermediate and High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
The Clatterbridge Cancer Centre NHS Foundation Trust 55
Not applicableStudy completedNCT01605097
What this trial is testing

High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 26
Not applicableStudy completedNCT04582656
What this trial is testing

Efficacy Assessment of a Novel 3D Cartography-based Targeted Focal Microwave Therapy in Men With Localized Intermediate-risk Prostate Cancer

Who this might be right for
Prostate Cancer
Koelis 76
Testing effectiveness (Phase 2)Study completedNCT01146340
What this trial is testing

Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate Cancer

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 30
Not applicableLooking for participantsNCT06451445
What this trial is testing

A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 100
Large-scale testing (Phase 3)Active Not RecruitingNCT06235151
What this trial is testing

Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Curium US LLC 439
Testing effectiveness (Phase 2)Looking for participantsNCT04402151
What this trial is testing

Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 50
Testing effectiveness (Phase 2)Looking for participantsNCT07801664
What this trial is testing

Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer

Who this might be right for
Prostate Cancer
NYU Langone Health 90
Next Page